Data provided by Nasdaq. Minimum 15 minutes delayed.
March 30, 2017
NantHealth Reports 72% Increase in Full Year 2016 Total Net Revenue to $100 Million With SaaS Revenue Increasing More Than 181% and Increasing GPS Cancer Adoption
GPS Cancer Adoption by Oncologists Increased in Q4: 264 Oncologists Ordered 1,286 GPS Commercial & Research Tests YTD, with 452 tests in Q4, of which 326 Commercial and 126 Research First Consecutive 100 GPS Cancer Tests Completed at a Single Academic Institution (Feb-Nov 2016) Demonstrating Significant Increase in Identification of an FDA Approved Drug or Clinical Trial for Patients with Refractory...
March 28, 2017
NantHealth to Report 2016 Fourth-Quarter, Full-Year Financial Results and Host Conference Call on Thursday, March 30
CULVER CITY, Calif.--(BUSINESS WIRE)--Mar. 28, 2017-- NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2016 fourth quarter and full year on Thursday, March 30, 2017, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance. The confer...
March 16, 2017
NantHealth and Dr. Soon-Shiong Send Letters to Statnews.com Listing Errors and Corresponding Facts
CULVER CITY, Calif.--(BUSINESS WIRE)--Mar. 16, 2017-- NantHealth and Dr. Patrick Soon-Shiong today sent two detailed letters to Statnews.com, listing inaccuracies of what was posted and then the facts. These two letters address in detail the multiple inaccuracies in Ms. Robbins’ reporting on NantHealth, Dr. Soon-Shiong’s foundation and Cancer MoonShot 2020. As just one example, in her reporting on Cancer MoonShot 2020, Ms. Robbins asserted...